Betaferon 250 microgram/ml, powder and solvent for solution for injection

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
13	多発性硬化症／視神経脊髄炎	15

13. 多発性硬化症／視神経脊髄炎

臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

trials per page:

Showing 1 to 10 of 15 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2017-001176-31-PT (EUCTR)	12/03/2018	01/03/2018	A long term follow up study to look at the progress of patients withsymptoms suggestive of MS who to ...	BENEFIT 15 long-term follow-up study of the BENEFIT and BENEFIT follow-up studies	Clinically-isolated syndrome (CIS) andmultiple sclerosis (MS) MedDRA version: 20.1;Level: PT;Classif ...	Trade Name: Betaferon 250 microgram/ml, powder and solvent for solution for injection Product Name: B ...	Bayer AG	,NULL	Not Recruiting			Female: yes Male: yes	300	Phase 4	Portugal;Slovenia;Finland;Spain;Austria;Israel;United Kingdom;Switzerland;Italy;France;Czech Republi ...
2	EUCTR2017-001176-31-CZ (EUCTR)	07/12/2017	03/08/2017	A long term follow up study to look at the progress of patients withsymptoms suggestive of MS who to ...	BENEFIT 15 long-term follow-up study of the BENEFIT and BENEFIT follow-up studies	Clinically-isolated syndrome (CIS) andmultiple sclerosis (MS) MedDRA version: 20.0;Level: PT;Classif ...	Trade Name: Betaferon 250 microgram/ml, powder and solvent for solution for injection Product Name: B ...	Bayer AG	,NULL	Not Recruiting			Female: yes Male: yes	300	Phase 4	Portugal;Slovenia;Finland;Spain;Austria;Israel;Italy;Switzerland;United Kingdom;Czech Republic;Hunga ...
3	EUCTR2017-001176-31-FR (EUCTR)	07/12/2017	16/01/2018	A long term follow up study to look at the progress of patients with symptoms suggestive of MS who t ...	BENEFIT 15 long-term follow-up study of the BENEFIT and BENEFIT follow-up studies	Clinically-isolated syndrome (CIS) andmultiple sclerosis (MS) MedDRA version: 20.1;Level: PT;Classif ...	Trade Name: Betaferon 250 microgram/ml, powder and solvent for solution for injection INN or Proposed ...	Bayer AG	,NULL	Not Recruiting			Female: yes Male: yes	300	Phase 4	Portugal;Slovenia;Finland;Spain;Austria;Israel;Italy;Switzerland;United Kingdom;France;Hungary;Czech ...
4	EUCTR2017-001176-31-GB (EUCTR)	06/11/2017	21/07/2017	A long term follow up study to look at the progress of patients with symptoms suggestive of MS who t ...	BENEFIT 15 long-term follow-up study of the BENEFIT and BENEFIT follow-up studies	Clinically-isolated syndrome (CIS) andmultiple sclerosis (MS) MedDRA version: 20.0;Level: PT;Classif ...	Trade Name: Betaferon 250 microgram/ml, powder and solvent for solution for injection Product Name: B ...	Bayer AG	,NULL	Not Recruiting			Female: yes Male: yes	300	Phase 4	Portugal;Slovenia;Finland;Spain;Austria;Israel;Italy;United Kingdom;Switzerland;France;Czech Republi ...
5	EUCTR2017-001176-31-DK (EUCTR)	25/10/2017	14/08/2017	A long term follow up study to look at the progress of patients withsymptoms suggestive of MS who to ...	BENEFIT 15 long-term follow-up study of the BENEFIT and BENEFIT follow-up studies	Clinically-isolated syndrome (CIS) andmultiple sclerosis (MS) MedDRA version: 20.0;Level: PT;Classif ...	Trade Name: Betaferon 250 microgram/ml, powder and solvent for solution for injection Product Name: B ...	Bayer AG	,NULL	Not Recruiting			Female: yes Male: yes	300	Phase 4	Portugal;Slovenia;Finland;Spain;Austria;Israel;Italy;Switzerland;United Kingdom;Czech Republic;Hunga ...
6	EUCTR2017-001176-31-ES (EUCTR)	20/09/2017	12/07/2017	A long term follow up study to look at the progress of patients with symptoms suggestive of MS who t ...	BENEFIT 15 long-term follow-up study of the BENEFIT and BENEFIT follow-up studies	Clinically-isolated syndrome (CIS) andmultiple sclerosis (MS) MedDRA version: 20.0;Level: PT;Classif ...	Trade Name: Betaferon 250 microgram/ml, powder and solvent for solution for injection Product Name: B ...	Bayer AG	NULL	Not Recruiting			Female: yes Male: yes	300	Phase 4	Finland;Spain;Austria;Israel;Italy;Switzerland;United Kingdom;Czech Republic;Hungary;Canada;Poland;B ...
7	EUCTR2017-001176-31-FI (EUCTR)	14/09/2017	10/08/2017	A long term follow up study to look at the progress of patients withsymptoms suggestive of MS who to ...	BENEFIT 15 long-term follow-up study of the BENEFIT and BENEFIT follow-up studies	Clinically-isolated syndrome (CIS) andmultiple sclerosis (MS) MedDRA version: 20.0;Level: PT;Classif ...	Trade Name: Betaferon 250 microgram/ml, powder and solvent for solution for injection Product Name: B ...	Bayer AG	,NULL	Not Recruiting			Female: yes Male: yes	300	Phase 4	Portugal;Slovenia;Finland;Spain;Austria;Israel;Italy;Switzerland;United Kingdom;Czech Republic;Hunga ...
8	EUCTR2017-001176-31-AT (EUCTR)	07/09/2017	26/07/2017	A long term follow up study to look at the progress of patients withsymptoms suggestive of MS who to ...	BENEFIT 15 long-term follow-up study of the BENEFIT and BENEFIT follow-up studies	Clinically-isolated syndrome (CIS) andmultiple sclerosis (MS) MedDRA version: 20.0;Level: PT;Classif ...	Trade Name: Betaferon 250 microgram/ml, powder and solvent for solution for injection Product Name: B ...	Bayer AG	,NULL	Not Recruiting			Female: yes Male: yes	300	Phase 4	Portugal;Slovenia;Finland;Spain;Austria;Israel;Italy;Switzerland;United Kingdom;Czech Republic;Hunga ...
9	EUCTR2012-005262-35-GB (EUCTR)	14/08/2013	11/06/2013	A long term follow up study to look at the progress of patients with symptoms suggestive of MS who t ...	BENEFIT 11 a long-term, follow-up study (16401) of the BENEFIT (304747), BENEFIT Follow-up (305207) ...	Clinically isolated syndrome (CIS) andmultiple sclerosis (MS) MedDRA version: 20.1;Level: PT;Classif ...	Trade Name: Betaferon 250 microgram/ml, powder and solvent for solution for injection Product Name: B ...	Bayer HealthCare AG	NULL	Not Recruiting			Female: yes Male: yes	468	Phase 4	Portugal;Slovenia;Finland;Spain;Austria;Israel;Italy;United Kingdom;Switzerland;France;Hungary;Czech ...
10	EUCTR2012-005262-35-IT (EUCTR)	14/08/2013	25/06/2013	A long term follow up study to look at the progress of patients with symptoms suggestive of MS who t ...	BENEFIT 11 a long-term, follow-up study (16401) of the BENEFIT (304747), BENEFIT Follow-up (305207) ...	Clinically isolated syndrome (CIS) andmultiple sclerosis (MS) MedDRA version: 14.1;Level: PT;Classif ...	Trade Name: Betaferon 250 microgram/ml, powder and solvent for solution for injection Product Name: B ...	Bayer HealthCare AG	NULL	Not Recruiting			Female: yes Male: yes	468		Portugal;Slovenia;Finland;Spain;Austria;Israel;Italy;Switzerland;United Kingdom;France;Hungary;Czech ...

First Previous1 2Next Last